Prescribing Patterns of Codeine and Alternative Medicines in Children in Europe

Introduction Concerns over serious respiratory depression in children led to two European Union (EU) referral procedures (in 2013 and 2015) to review the benefit–risk balance of codeine in this population when used for pain relief, cough or cold. Consequently, codeine should no longer be used in chi...

Full description

Saved in:
Bibliographic Details
Published in:Drug safety 2022-10, Vol.45 (10), p.1069-1081
Main Authors: Plueschke, Kelly, Flynn, Robert, Hedenmalm, Karin, Deli, Aikaterini-Christina, Maciá-Martinez, Miguel-Angel, García-Poza, Patricia, Olsen, David, Nguyen, Pierre, Quinten, Chantal
Format: Article
Language:English
Subjects:
Age
Analgesics
Anti-inflammatory agents
Breastfeeding & lactation
Children
Codeine
Cold
Collaboration
Communication
Cough
Drug Safety and Pharmacovigilance
Electronic health records
Electronic medical records
Health care
Indication
Medicine
Medicine & Public Health
Morphine
Narcotics
Opioids
Original
Original Research Article
Pain
Pain management
Pain perception
Pediatrics
Pharmacology/Toxicology
Pharmacovigilance
Product safety
Public health
Trends
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction Concerns over serious respiratory depression in children led to two European Union (EU) referral procedures (in 2013 and 2015) to review the benefit–risk balance of codeine in this population when used for pain relief, cough or cold. Consequently, codeine should no longer be used in children aged
ISSN:0114-5916
1179-1942
DOI:10.1007/s40264-022-01214-y